INHALED PLATELET-ACTIVATING-FACTOR WORSENS GAS-EXCHANGE IN MILD ASTHMA

被引:32
作者
FELEZ, MA
ROCA, J
BARBERA, JA
SANTOS, C
ROTGER, M
CHUNG, KF
RODRIGUEZROISIN, R
机构
[1] UNIV BARCELONA,HOSP CLIN BARCELONA,FAC MED,BIOPHYS & BIOENGN LAB,SERV PNEUMOL & ALLERGIA RES,E-08036 BARCELONA,SPAIN
[2] ROYAL BROMPTON HOSP,NATL HEART & LUNG INST,DEPT THORAC MED,LONDON,ENGLAND
关键词
D O I
10.1164/ajrccm.150.2.8049817
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
To investigate the potential effects of inhaled platelet-activating-factor (PAF) (12 mu g) to perturb pulmonary gas exchange in bronchial asthma, six patients (mean +/- SE, 23 +/- 2 yr) with intermittent asthma (FEV(1), 90% predicted) were studied before and 5, 15, and 45 min after challenge. Circulating white blood cells, respiratory system resistance (Rrs), systemic and pulmonary hemodynamics, and respiratory and inert pulmonary gas exchange were measured. Five minutes after PAF leukocytes fell, Rrs increased (by 27%). PaO2 decreased (by 15 mm Hg), and AaPO(2) increased (twofold) (p < 0.05 each). Ventilation-perfusion (VA/Q) distributions worsened in a pattern similar to that commonly observed in patients with moderate to severe asthma. Dispersions of pulmonary blood flow (log SD Q) and of alveolar ventilation (log SD V), and an overall index of VA/Q heterogeneity (DISP R-E*) increased significantly (123% for DISP R-E*; p < 0.05, each). Gas exchange indices and Rrs were still minimally abnormal at 15 min but returned towards baseline at 45 min. Ventilatory and hemodynamic variables remained unaltered throughout the study. These results suggest that endogenous PAF may be implicated in the arterial blood gas abnormalities shown during exacerbations of bronchial asthma.
引用
收藏
页码:369 / 373
页数:5
相关论文
共 31 条
[1]   THE RELEASE OF PLATELET-ACTIVATING-FACTOR INTO PLASMA DURING ALLERGEN-INDUCED BRONCHOCONSTRICTION [J].
CHANYEUNG, M ;
LAM, S ;
CHAN, H ;
TSE, KS ;
SALARI, H .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1991, 87 (03) :667-673
[2]  
CHRISTMAN BW, 1988, J APPL PHYSIOL, V64, P2031
[3]   EFFECTS OF PLATELET ACTIVATING FACTOR ON AIRWAY CALIBER, AIRWAY RESPONSIVENESS, AND CIRCULATING CELLS IN ASTHMATIC SUBJECTS [J].
CHUNG, KF ;
BARNES, PJ .
THORAX, 1989, 44 (02) :108-115
[4]   PLATELET-ACTIVATING-FACTOR IN INFLAMMATION AND PULMONARY DISORDERS [J].
CHUNG, KF .
CLINICAL SCIENCE, 1992, 83 (02) :127-138
[5]   COMPLEMENT AND LEUKOCYTE-MEDIATED PULMONARY DYSFUNCTION IN HEMODIALYSIS [J].
CRADDOCK, PR ;
FEHR, J ;
BRIGHAM, KL ;
KRONENBERG, RS ;
JACOB, HS .
NEW ENGLAND JOURNAL OF MEDICINE, 1977, 296 (14) :769-774
[6]   LIMITS ON VA-Q DISTRIBUTIONS FROM ANALYSIS OF EXPERIMENTAL INERT-GAS ELIMINATION [J].
EVANS, JW ;
WAGNER, PD .
JOURNAL OF APPLIED PHYSIOLOGY, 1977, 42 (06) :889-898
[7]   VENTILATION-PERFUSION INEQUALITY IN NORMAL HUMANS DURING EXERCISE AT SEA-LEVEL AND SIMULATED ALTITUDE [J].
GALE, GE ;
TORREBUENO, JR ;
MOON, RE ;
SALTZMAN, HA ;
WAGNER, PD .
JOURNAL OF APPLIED PHYSIOLOGY, 1985, 58 (03) :978-988
[8]   INCREASED PLASMA PLATELET-ACTIVATING-FACTOR IN CHILDREN WITH ACUTE ASTHMATIC ATTACKS AND DECREASED INVIVO AND INVITRO PRODUCTION OF PLATELET-ACTIVATING-FACTOR AFTER IMMUNOTHERAPY [J].
HSIEH, KH ;
NG, CK .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1993, 91 (02) :650-657
[9]  
JOHNSON PRA, 1992, EUR RESPIR J, V5, P970
[10]   EFFECT OF THE PLATELET-ACTIVATING-FACTOR ANTAGONIST UK-74,505 ON THE EARLY AND LATE RESPONSE TO ALLERGEN [J].
KUITERT, LM ;
HUI, KP ;
UTHAYARKUMAR, S ;
BURKE, W ;
NEWLAND, AC ;
UDEN, S ;
BARNES, NC .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (01) :82-86